American Society of Hirudotherapy

Antibacterial non-glycosidase activity of invertebrate destabilase-lysozyme and of its helical amphipathic peptides

Basic science published in Chemotherapy (2006)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Antimicrobial ResistanceSalivary PharmacologyZavalova LL et al. · Chemotherapy, 2006

Abstract

BACKGROUND: Since bactericidal properties of some lysozymes are independent of their glycosidase activity, we have investigated this phenomenon for destabilase-lysozyme (DL) from medicinal leech (Hirudo medicinalis). METHODS: Glycosidase activity was determined on Micrococcus luteus, non-enzymatic antibacterial activity of heat-treated DL and of synthetic peptides alpha1, alpha2 and alpha3 (fragments of its primary structure) on M. luteus, Escherichia coli, Bacillus brevis and Streptomyces chrysomallus. RESULTS: Glycosidase activity disappeared after the heating of native DL at 100 degrees C for 40 min. Antibacterial activity of heat-treated DL for M. luteus MDMSU128 and MDMSU140 expressed as minimal inhibitory concentration was 9.8.10(-8) and 12.10(-8) M, respectively, and to E. coli MDMSU52 11.10(-8) M. Antibacterial activity of synthetic peptide alpha1 for M. luteus MDMSU128 and for E. coli MDMSU52 was 8.3.10(-5) and 4.9.10(-5) M, respectively. CONCLUSION: DL is the first invertebrate lysozyme with combined enzymatic and non-enzymatic antibacterial action.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsAnti-Infective AgentsBacteriaEndopeptidasesGlycoside HydrolasesHirudo medicinalisMicrobial Sensitivity TestsPeptide Fragments

Summary

Heat-treated destabilase retains antibacterial activity (MIC 9.8-12x10^-8 M) against M. luteus and E. coli even with glycosidase function abolished.

Why This Matters for Hirudotherapy

This study investigated the antibacterial properties of destabilase-lysozyme (DL) from the medicinal leech (Hirudo medicinalis), specifically examining its non-enzymatic, non-glycosidase antibacterial action. It is highly relevant to the leech secretome, demonstrating that heat-treated DL and synthetic peptides derived from its structure retain potent antibacterial activity against pathogens like Micrococcus luteus and Escherichia coli. This reveals that leech-derived molecules possess a dual enzymatic and non-enzymatic defense mechanism. However, the scope is limited to in vitro microbial sensitivity testing of isolated or synthetic leech peptides, providing no data on the efficacy of these compounds in live animal models or clinical hirudotherapy.

Citation

Antibacterial non-glycosidase activity of invertebrate destabilase-lysozyme and of its helical amphipathic peptides.

Zavalova LL et al. · Chemotherapy, 2006

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.